FDA
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $15 at Oppenheimer
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $27 at RBC Capital
-
-
-
-
-
-
-
Perspective Therapeutics to Participate at Upcoming April Investor Conferences
-
-
-
-
-
-
-
Perspective Therapeutics Reports First Quarter Fiscal 2023 Results
-
-
323,582 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

